Muscle weakness

For patient information, click here


 * Associate Editor(s)-In-Chief:

Overview
Muscle weakness (or "lack of strength") is a direct term for the inability to exert force with ones muscles to the degree that would be expected given the individual's general physical fitness. A test of strength is often used during a diagnosis of a muscular disorder before the etiology can be identified. Such etiology depends on the type of muscle weakness, which can be true or perceived as well as variable topically. True weakness is substantial, while perceived rather is a sensation of having to put more effort to do the same task. On the other hand, various topic locations for muscle weakness are central, neural and peripheral. Central muscle weakness is an overall exhaustion of the whole body, while peripheral weakness is an exhaustion of individual muscles. Neural weakness are somewhere between.

Muscle weakness can be a result of vigorous exercise but abnormal fatigue may be caused by barriers to or interference with the different stages of muscle contraction.

In a broader sense, muscle weakness is the physical part of fatigue (medical).

Acute/Sub Acute

 * Acute peripheral neuropathy
 * Corticosteroids
 * Coxsackie
 * Dermatomyositis
 * Herpes zoster
 * HIV
 * Hypercalcemia
 * Hyperkalemia
 * Hypermagnesemia
 * Hypoglycemia
 * Hypokalemia
 * Hypophosphatemia
 * Influenza
 * Liver Disease
 * Organophosphates
 * Poliomyelitis
 * Polymyositis
 * Rabies
 * Rhabdomyolysis
 * Thyrotoxicosis
 * Uremia

Chronic Muscle Weakness

 * Acromegaly
 * Adrenocorticol insufficiency
 * Alcoholic myopathy
 * Amyotrophic lateral sclerosis
 * Charcot-Marie-Tooth Disease
 * Chronic fatigue syndrome
 * Chronic infection
 * Chronic peripheral neuropathy
 * Cushing's Syndrome
 * Depression
 * Dermatomyositis
 * Diabetic neuropathy
 * Drugs/toxins
 * Duchenne's muscular dystrophy
 * Eaton-Lambert syndrome
 * Facioscapulohumeral
 * Glycogen Storage Disease
 * Hypercalcemia
 * Hyperkalemia
 * Hyperthyroidism
 * Hyperparathyroidism
 * Hypoglycemia
 * Hypokalemia
 * Hypophosphatemia
 * Hypothyroidism
 * Inflammatory myopathy
 * Lipid storage disease
 * Liver Disease
 * Lupus erythematosus
 * Malignant tumor
 * Malnutrition
 * Mitochondrial myopathy
 * Mitral Regurgitation
 * Mitral Stenosis
 * Mixed Connective Tissue Disease
 * Multiple Sclerosis
 * Myasthenia gravis
 * Myotonic
 * Oculopharyngeal
 * Physical deconditioning
 * Polymyositis
 * Rhabdomyolysis
 * Rheumatoid Arthritis
 * Sjogren's Syndrome
 * Somatization syndrome
 * Steroid myopathy
 * Uremia
 * Vitamin D deficiency

Complete Differential Diagnosis of Causes of Muscle weakness
(In alphabetical order)


 * 3-Methylglutaconic aciduria
 * 3-Quinuclidinyl benzilate
 * Acamprosate
 * Accessory nerve disorder
 * Acitretin
 * Acute intermittent porphyria
 * Acute peripheral neuropathy
 * Acute viral nasopharyngitis (common cold)
 * Addison's disease
 * Adrenal carcinoma
 * Alcoholic polyneuropathy
 * Aluminum Hydroxide
 * Amiloride and Hydrochlorothiazide
 * Amiodarone Oral
 * Amyotrophic lateral sclerosis
 * Anorexia nervosa
 * Arnold-Chiari malformation
 * Arthrogryposis
 * Autism
 * Bassen-Kornzweig syndrome
 * Becker's muscular dystrophy
 * Beclomethasone Oral Inhalation
 * Benztropine Mesylate Oral
 * Bezafibrate
 * Botulism
 * Brachial plexus injury
 * Brompheniramine
 * Budesonide Inhalation Powder
 * Bulimia nervosa
 * Cadmium poisoning
 * Carnitine palmitoyltransferase I deficiency
 * Chloroquine Phosphate Oral
 * Chlorothiazide
 * Chlorpheniramine
 * Chlorthalidone
 * Chronic fatigue syndrome
 * Chronic inflammatory demyelinating polyneuropathy
 * Ciclesonide Nasal Spray
 * Cirrhosis
 * Clofibrate
 * Colistimethate Injection
 * Congenital muscular dystrophy
 * Congenital myasthenic syndrome
 * Congenital myopathy
 * Connective tissue disease
 * Cushing's syndrome
 * Cyanocobalamin Injection
 * Cyproheptadine
 * Cytarabine
 * Daptomycin
 * Decompression sickness
 * Dejerine Sottas syndrome
 * Dermatomyositis
 * Desipramine
 * Devic's disease
 * Dexamethasone Oral
 * Dextroamphetamine and Amphetamine
 * Diabetic amyotrophy
 * Diabetic neuropathy
 * Dicamba
 * Dicyclomine
 * Diphenhydramine Oral
 * Donepezil
 * Dorzolamide and Timolol Ophthalmic
 * Doxazosin
 * Doxylamine
 * Duchenne muscular dystrophy
 * Emery-Dreifuss Muscular Dystrophy
 * Engelmann syndrome
 * Epidural hematoma
 * Exercise intolerance
 * Ezetimibe
 * Facioscapulohumeral muscular dystrophy
 * Fexofenadine and Pseudoephedrine
 * Fludrocortisone Acetate
 * Flunisolide Nasal Inhalation
 * Fluoride poisoning
 * Fluticasone and Salmeterol Oral Inhalation
 * Fluvastatin
 * Frailty syndrome
 * Friedreich's ataxia
 * Galantamine
 * Gemeprost
 * Glucocorticoids
 * Glutaric aciduria type 1
 * Glycogen storage disease type II
 * GM1 gangliosidoses
 * Graves' Disease
 * Group A streptococcal infection
 * Guanidinoacetate methyltransferase deficiency
 * Guillain-Barre syndrome
 * Hereditary inclusion body myopathy
 * Hereditary spastic paraplegia
 * Herpes zoster
 * Hexane-2,5-dione
 * HIV
 * Hopkins syndrome
 * Hydrochlorothiazide
 * Hydrocortisone Injection
 * Hydrocortisone Oral
 * Hydroxychloroquine
 * Hydroxyzine
 * Hyperaldosteronism
 * Hypercalcemia
 * Hyperkalaemic periodic paralysis


 * Hyperkalemia
 * Hypermagnesemia
 * Hypermethioninemia
 * Hyperpituitarism
 * Hyperthyroidism
 * Hypoglycemia
 * Hypokalemic periodic paralysis
 * Hypomagnesemia
 * Hypophosphatemia
 * Hypothyroidism
 * Imiquimod
 * Inclusion body myositis
 * Influenza
 * Interferon Beta-1b Injection
 * Juvenile dermatomyositis
 * Juvenile primary lateral sclerosis
 * Kennedy disease
 * Krabbe disease
 * Lambert-Eaton myasthenic syndrome
 * Leflunomide
 * Letrozole
 * Levalbuterol Oral Inhalation
 * Limb-girdle muscular dystrophy
 * Lisinopril and Hydrochlorothiazide
 * Lithium
 * Loprazolam
 * Lormetazepam
 * Lovastatin
 * Low-carbohydrate diet
 * Machado-Joseph disease
 * Marinesco-Sjogren syndrome
 * Mepyramine
 * Metabolic acidosis
 * Metachromatic leukodystrophy
 * Methyclothiazide
 * Methyldopa and Hydrochlorothiazide
 * Methylprednisolone Oral
 * Metolazone
 * Mitochondrial trifunctional protein deficiency
 * Motor neurone disease
 * Multiple sclerosis
 * Myasthenia gravis
 * Nelson's syndrome
 * Nemaline myopathy
 * Nitrazepam
 * Nitrofurantoin
 * Oxcarbazepine
 * Peripheral Arterial Disease
 * Peripheral neuropathy
 * Phosphofructokinase deficiency
 * Poliomyelitis
 * Polymyositis
 * Postherpetic neuralgia
 * Post-polio syndrome
 * Pott's disease
 * Pramipexole
 * Pravastatin
 * Prazosin and polythiazide
 * Prednisone
 * Primary carnitine deficiency
 * Primary hyperparathyroidism
 * Primary lateral sclerosis
 * Procyclidine
 * Pseudoephedrine and triprolidine
 * Pyridostigmine
 * Pyruvate carboxylase deficiency
 * Reserpine, hydralazine, and hydrochlorothiazide
 * Rhabdomyolysis
 * Rhabdomyolysis
 * Rheumatoid Arthritis
 * Rhinovirus
 * Riluzole
 * Rosuvastatin
 * Salmeterol oral inhalation
 * Sandhoff disease
 * Schilder's disease
 * Scleroderma
 * Selegiline
 * Sjogren's Syndrome
 * Small fiber peripheral neuropathy
 * Somatization disorder
 * Spinal cord injury
 * Spinal disc herniation
 * Spinal stenosis
 * Spironolactone
 * Spondylosis
 * Sturge-Weber syndrome
 * Tabes dorsalis
 * Tamoxifen
 * Telbivudine
 * Temik
 * Tension myositis syndrome
 * Teriparatide (rDNA origin) Injection
 * Thyrotoxicosis
 * Tocopherol
 * Topiramate
 * Trastuzumab
 * Triamcinolone Nasal Inhalation
 * Triamterene
 * Trimeprazine
 * Uremia
 * Variegate porphyria
 * Vitamin D deficiency
 * Walker-Warburg syndrome
 * Zoledronic Acid Injection

Complete Differential Diagnosis of the Causes of Muscle weakness
(By organ system)

Muscle contraction
Muscle cells work by detecting a flow of electrical impulses from the brain which signals them to contract through the release of calcium by the sarcoplasmic reticulum. Fatigue (reduced ability to generate force) may occur due to the nerve, or within the muscle cells themselves.

True vs. perceived
The term subsumes two other more specific terms, true weakness and perceived weakness.


 * True weakness (or "objective weakness") describes a condition where the instantaneous force exerted by the muscles is less than would be expected. For instance, if a patient suffers from amyotrophic lateral sclerosis (ALS), motor neurons are damaged and can no longer stimulate the muscles to exert normal force.


 * Perceived weakness (or "subjective weakness") describes a condition where it seems to the patient that more effort than normal is required to exert a given amount of force. For instance, in some people with chronic fatigue syndrome (CFS) who may struggle to climb a set of stairs when feeling especially fatigued, their muscle strength when objectively measured (eg, the maximum weight they can press with their legs) is essentially normal, though this is not true for CFS patients who may be disabled through post-exertional weakness/malaise etc. and in severe cases may not be able to climb a flight of stairs.

In some conditions, such as myasthenia gravis muscle strength is normal when resting, but true weakness occurs after the muscle has been subjected to exercise. This is also true for some cases of CFS, where objective post-exertion muscle weakness with delayed recovery time has been measured and is a feature of some of the published definitions. .

Topically
In addition to true/perceived, muscle weaknes can also be central, neural and peripheral. Central muscle weakness manifests as an overall, bodily or systemic, sense of energy deprivation, and peripheral weakness manifests as a local, muscle-specific incapacity to do work. . Neural weakness can be both central and peripheral.

Central
The central component to muscle fatigue is generally described in terms of a reduction in the neural drive or nerve-based motor command to working muscles that results in a decline in the force output. It has been suggested that the reduced neural drive during exercise may be a protective mechanism to prevent organ failure if the work was continued at the same intensity. The exact mechanisms of central fatigue are unknown although there has been a great deal of interest in the role of serotonergic pathways.

Neural
Nerves are responsible for controlling the contraction of muscles, determining the number, sequence and force of muscular contraction. Most movements require a force far below what a muscle could in potential generate, and barring pathology nervous fatigue is seldom an issue. For extremely powerful contractions that are close to the upper limit of a muscle's ability to generate force, nervous fatigue can be a limiting factor in untrained individuals. In novice strength trainers, the muscle's ability to generate force is most strongly limited by nerve’s ability to sustain a high-frequency signal. After a period of maximum contraction, the nerve’s signal reduces in frequency and the force generated by the contraction diminishes. There is no sensation of pain or discomfort, the muscle appears to simply ‘stop listening’ and gradually cease to move, often going backwards. As there is insufficient stress on the muscles and tendons, there will often be no delayed onset muscle soreness following the workout. Part of the process of strength training is increasing the nerve's ability to generate sustained, high frequency signals which allow a muscle to contract with their greatest force. It is this neural training that causes several weeks worth of rapid gains in strength, which level off once the nerve is generating maximum contractions and the muscle reaches its physiological limit. Past this point, training effects increase muscular strength through myofibrilar or sarcoplasmic hypertrophy and metabolic fatigue becomes the factor limiting contractile force.

Peripheral
Peripheral muscle fatigue during physical work is considered an inability for the body to supply sufficient energy or other metabolites to the contracting muscles to meet the increased energy demand. This is the most common case of physical fatigue--affecting a national average of 72% of adults in the work force in 2002. This causes contractile dysfunction that is manifested in the eventual reduction or lack of ability of a single muscle or local group of muscles to do work. The insufficiency of energy, i.e. sub-optimal aerobic metabolism, generally results in the accumulation of lactic acid and other acidic anaerobic metabolic by-products in the muscle, causing the stereotypical burning sensation of local muscle fatigue.

The fundamental difference between the peripheral and central theories of muscle fatigue is that the peripheral model of muscle fatigue assumes failure at one or more sites in the chain that initiates muscle contraction. Peripheral regulation is therefore dependent on the localised metabolic chemical conditions of the local muscle affected, whereas the central model of muscle fatigue is an integrated mechanism that works to preserve the integrity of the system by initiating muscle fatigue through muscle derecruitment, based on collective feedback from the periphery, before cellular or organ failure occurs. Therefore the feedback that is read by this central regulator could include chemical and mechanical as well as cognitive cues. The significance of each of these factors will depend on the nature of the fatigue-inducing work that is being performed.

Though not universally used, ‘metabolic fatigue’ is a common alternative term for peripheral muscle weakness, because of the reduction in contractile force due to the direct or indirect effects of the reduction of substrates or accumulation of metabolites within the muscle fiber. This can occur through a simple lack of energy to fuel contraction, or interference with the ability of Ca2+ to stimulate actin and myosin to contract.

Substrates
Substrates within the muscle generally serve to power muscular contractions. They include molecules such as adenosine triphosphate (ATP), glycogen and creatine phosphate. ATP binds to the myosin head and causes the ‘ratchetting’ that results in contraction according to the sliding filament model. Creatine phosphate stores energy so ATP can be rapidly regenerated within the muscle cells from adenosine diphosphate (ADP) and inorganic phosphate ions, allowing for sustained powerful contractions that last between 5-7 seconds. Glycogen is the intramuscular storage form of glucose, used to generate energy quickly once intramuscular creatine stores are exhausted, producing lactic acid as a metabolic byproduct.

Substrates produce metabolic fatigue by being depleted during exercise, resulting in a lack of intracellular energy sources to fuel contractions. In essence, the muscle stops contracting because it lacks the energy to do so.

Metabolites
Metabolites are the substances (generally waste products) produced as a result of muscular contraction. They include ADP, Mg2+, reactive oxygen species and inorganic phosphate. Accumulation of metabolites can directly or indirectly produce metabolic fatigue within muscle fibers through interference with the release of calcium from the sarcoplasmic reticulum or reduction of the sensitivity of contractile molecules actin and myosin to calcium.

Chloride
Intracellular chloride inhibits the contraction of muscles, preventing them from contracting due to "false alarms", small stimuli which may cause them to contract (akin to myoclonus). This natural brake helps muscles respond solely to the conscious control or spinal reflexes but also has the effect of reducing the force of conscious contractions.

Potassium
High concentrations of potassium also causes the muscle cells to decrease in efficiency, causing cramping and fatigue. Potassium builds up in the t-tubule system and around the muscle fiber in general. This has the effect of depolarizing the muscle fiber, preventing the sodium-potassium pump from moving Na+ out of the cell. This reduces the amplitude of action potentials, or stops them entirely, resulting in neurological fatigue.

Lactic acid
It was once believed that lactic acid build-up was the cause of muscle fatigue. The assumption was lactic acid had a "pickling" effect on muscles, inhibiting their ability to contract. The impact of lactic acid on performance is now uncertain, it may assist or hinder muscle fatigue.

Produced as a by-product of fermentation, lactic acid can increase intracellular acidity of muscles. This can lower the sensitivity of contractile apparatus to Ca2+ but also has the effect of increasing cytoplasmic Ca2+ concentration through an inhibition of the chemical pump that actively transports calcium out of the cell. This counters inhibiting effects of K+ on muscular action potentials. Lactic acid also has a negating effect on the chloride ions in the muscles, reducing their inhibition of contraction and leaving potassium ions as the only restricting influence on muscle contractions, though the effects of potassium are much less than if there were no lactic acid to remove the chloride ions. Ultimately, it is uncertain if lactic acid reduces fatigue through increased intracellular calcium or increases fatigue through reduced sensitivity of contractile proteins to Ca2+.

Associated conditions
Muscle weakness may be due to problems with the nerve supply, neuromuscular disease such as myasthenia gravis) or problems with muscle itself. The latter category includes polymyositis and other muscle disorders


 * Amyotrophic lateral sclerosis
 * Botulism
 * Centronuclear myopathy
 * Myotubular myopathy
 * Dysautonomia
 * Charcot-Marie-Tooth disease
 * Hypokalemia
 * Motor neurone disease
 * Muscular dystrophy
 * Myasthenia Gravis
 * Progressive muscular atrophy
 * Spinal muscular atrophy
 * Cerebral palsy
 * Infectious mononucleosis
 * Herpes Zoster
 * Vitamin D deficiency
 * Fibromyalgia
 * Celiac Disease
 * Hypercortisolism (Cushing's syndrome)
 * Hypocortisolism (Addison's disease)
 * Primary hyperaldosteronism (Conn's syndrome)
 * Ehlers-Danlos syndrome

Diagnostic Findings
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology